MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

Search

Alcon Inc

Avatud

SektorTervishoid

81.01 -0.98

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

80.78

Max

82.45

Põhinäitajad

By Trading Economics

Sissetulek

55M

238M

Müük

18M

2.6B

P/E

Sektori keskmine

38.405

87.826

Dividenditootlus

0.41

Kasumimarginaal

9.11

Töötajad

25,000

EBITDA

415M

665M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+11.38% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.41%

2.26%

Turustatistika

By TradingEconomics

Turukapital

3B

40B

Eelmine avamishind

81.99

Eelmine sulgemishind

81.01

Uudiste sentiment

By Acuity

40%

60%

132 / 373 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Alcon Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. jaan 2026, 15:11 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9. dets 2025, 18:51 UTC

Omandamised, ülevõtmised, äriostud

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9. dets 2025, 15:54 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9. dets 2025, 14:32 UTC

Omandamised, ülevõtmised, äriostud

Alcon Upgrades Offer Price for Staar Surgical

12. nov 2025, 09:09 UTC

Tulu
Suurimad hinnamuutused turgudel

Alcon Shares in Switzerland Climb After Guidance Confirmation

6. jaan 2026, 22:03 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6. jaan 2026, 22:03 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6. jaan 2026, 15:21 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6. jaan 2026, 14:56 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6. jaan 2026, 14:14 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6. jaan 2026, 14:14 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6. jaan 2026, 14:14 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6. jaan 2026, 14:13 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9. dets 2025, 14:17 UTC

Omandamised, ülevõtmised, äriostud

Alcon Ups Offer Price for Staar Surgical

9. dets 2025, 13:34 UTC

Omandamised, ülevõtmised, äriostud

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9. dets 2025, 13:33 UTC

Omandamised, ülevõtmised, äriostud

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9. dets 2025, 13:33 UTC

Omandamised, ülevõtmised, äriostud

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9. dets 2025, 13:33 UTC

Omandamised, ülevõtmised, äriostud

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9. dets 2025, 13:32 UTC

Omandamised, ülevõtmised, äriostud

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9. dets 2025, 13:32 UTC

Omandamised, ülevõtmised, äriostud

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

9. dets 2025, 13:31 UTC

Omandamised, ülevõtmised, äriostud

Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC

9. dets 2025, 13:31 UTC

Omandamised, ülevõtmised, äriostud

Alcon Announces Amended Merger Agreement With STAAR Surgical

9. dets 2025, 13:31 UTC

Omandamised, ülevõtmised, äriostud

Alcon Enters Amended Merger Agreement for Acquisition of STAAR Surgical >ALC

12. nov 2025, 08:46 UTC

Market Talk

Alcon's Guidance Reiteration Offers Relief -- Market Talk

11. nov 2025, 21:35 UTC

Tulu

Alcon 3Q Adj EPS 79c >ALC

11. nov 2025, 21:35 UTC

Tulu

Alcon 3Q Rev $2.61B >ALC.EB

11. nov 2025, 21:35 UTC

Tulu

Alcon Backs 2025 EPS $3.05-EPS $3.15 >ALC.EB

11. nov 2025, 21:35 UTC

Tulu

Alcon 3Q EPS 48c >ALC.EB

11. nov 2025, 21:34 UTC

Tulu

Alcon Backs 2025 Adj EPS $3.05-Adj EPS $3.15 >ALC

11. nov 2025, 21:34 UTC

Tulu

Alcon Backs 2025 Net Sales $10.3B-$10.4B >ALC

Võrdlus sarnastega

Hinnamuutus

Alcon Inc Prognoos

Hinnasiht

By TipRanks

11.38% tõus

12 kuu keskmine prognoos

Keskmine 91.12 USD  11.38%

Kõrge 113.265 USD

Madal 75.51 USD

Põhineb 12 Wall Streeti analüütiku instrumendi Alcon Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

12 ratings

8

Osta

3

Hoia

1

Müü

Tehniline skoor

By Trading Central

95.77 / 97.61Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

132 / 373 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat